Status:
COMPLETED
Evaluation of Quality of Care - Haemodialysis Public-Private-Partnership, Hospital Authority
Lead Sponsor:
The University of Hong Kong
Collaborating Sponsors:
Hospital Authority, Hong Kong
Conditions:
End-stage Renal Failure (ESRF)
Eligibility:
All Genders
18+ years
Brief Summary
Patients with end-stage renal failure (ESRF) have lost the function to excrete urea and maintain electrolyte balance, which is lethal unless they are given renal replacement therapy (Gibney, Hoste et ...
Eligibility Criteria
Inclusion
- Patients currently being followed up at the HA on haemodialysis, peritoneal dialysis, or are new ESRF cases will be recruited.
Exclusion
- Patients who do not have a good vascular access, are not hemodynamically stable for HD, are not mentally sound, ambulatory and independent, are unable to understand and communicate in Chinese language, or refuse to give consent will be excluded from the HD PPP programme.
Key Trial Info
Start Date :
September 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2017
Estimated Enrollment :
125 Patients enrolled
Trial Details
Trial ID
NCT02307903
Start Date
September 1 2010
End Date
April 1 2017
Last Update
September 6 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Hong Kong
Hong Kong Island, Hong Kong